Unlearn.AI

SmartTechText Analytics

Unlearn.AI provides a platform that accelerates drug development by pioneering computational clinical trials.

2017

Founded

Age

$85M

Total funding

Text Analytics

Area

Funding timeline

Mar 2023

Venture Round - Unlearn.AI

$15M

Apr 2022

Series B - Unlearn.AI

$50M

Nov 2020

Series A

$3M

Apr 2020

Series A - Unlearn.AI

$12M

Mar 2019

Seed Round - Unlearn.AI

$4M

Aug 2017

Pre Seed Round - Unlearn.AI

$650K